Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-12 4:01 pm Sale | 13D | Skillz Inc. SKLZ | Wildcat Capital Management LLC | 0 0.000% | -19,596,988 (Position Closed) | View |
| 2024-08-22 6:44 pm Purchase | 13D | Silexion Therapeutics Corp SLXN | Wildcat Capital Management LLC | 1,020,852 10.500% | 1,020,852 (New Position) | View |
| 2024-04-08 4:41 pm Purchase | 13G | Frontier Group Holdings Inc. ULCC | Wildcat Capital Management LLC | 28,061,351 12.600% | 28,061,351 (New Position) | View |
| 2023-01-05 4:11 pm Sale | 13D | Skillz Inc. SKLZ | Wildcat Capital Management LLC | 19,596,988 5.570% | -1,668,831 (-7.85%) | View |
| 2022-02-14 4:15 pm Sale | 13G | UROGEN PHARMA LTD URGN | Wildcat Capital Management LLC | 533,139 2.400% | -719,146 (-57.43%) | View |
| 2021-03-23 4:33 pm Sale | 13D | Skillz Inc. SKLZ | Wildcat Capital Management LLC | 21,265,819 6.700% | -566,203 (-2.59%) | View |
| 2021-03-08 5:14 pm Purchase | 13D | Skillz Inc. SKLZ | Wildcat Capital Management LLC | 21,832,022 7.500% | 398,982 (+1.86%) | View |
| 2021-02-12 4:10 pm Purchase | 13G | UROGEN PHARMA LTD URGN | Wildcat Capital Management LLC | 1,252,285 5.670% | 96,423 (+8.34%) | View |
| 2020-12-31 4:24 pm Sale | 13D | Skillz Inc. SKLZ | Wildcat Capital Management LLC | 21,433,040 7.300% | -10 (-0.00%) | View |
| 2020-12-28 4:47 pm Purchase | 13D | Skillz Inc. SKLZ | Wildcat Capital Management LLC | 21,433,050 7.300% | 21,433,050 (New Position) | View |
| 2020-02-14 4:27 pm Purchase | 13G | UROGEN PHARMA LTD URGN | Wildcat Capital Management LLC | 1,155,862 5.510% | 99,800 (+9.45%) | View |